Connect with us

International

Cancer drug cooperation could save 1.5 mn lives a year: researchers

Ilustrative image

AFP

Around 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs, researchers said Tuesday.

The figure was based on how long it took two recent cancer drugs to be approved across the world after they were given the green light by the United States.

Pembrolizumab, an effective treatment for most lung cancers, was approved by the US Food and Drug Administration (FDA) in 2016.

More than 600,000 years of patients’ lives could have been saved if Brazil, Canada, China, India, Japan and the European Union had approved the drug at the same time, according to an analysis published in the Harvard Business Review, which is not peer-reviewed.

Advertisement
20241211_mh_noexigencia_dui_728x90
20240813_lechematerna_728x91
20240701_vacunacion_728x90
20231124_etesal_728x90_1
domfuturo_netview-728x90
20240604_dom_728x90
20230816_dgs_728x90
20230601_agenda_primera_infancia_728X90
CEL
previous arrow
next arrow

The authors, including US oncologist Bobby Daly, also looked at enzalutamide, which is used to treat prostate cancer.

Enzalutamide was approved by the FDA in 2012, but was not authorised in China for another seven years, partly due to a requirement for separate trials to be carried out there.

The analysis by members of the Bloomberg New Economy International Cancer Coalition found that 284,000 years of patient lives could have been saved if other countries had approved the drug alongside the FDA.

Extrapolating out from their findings, the researchers estimated that if each of the approximately seven cancer drugs approved by the FDA a year were authorised worldwide, it would reduce the number of cancer-related deaths by 10-20 percent. 

That represents roughly 1.5 million of the around 10 million people who die of cancer every year.

Advertisement
20241211_mh_noexigencia_dui_728x90
20240813_lechematerna_728x91
20240701_vacunacion_728x90
20231124_etesal_728x90_1
domfuturo_netview-728x90
20240604_dom_728x90
20230816_dgs_728x90
20230601_agenda_primera_infancia_728X90
CEL
previous arrow
next arrow

‘Challenging’ for doctors

“In China alone an estimated 500,000 patient life-years could be saved through harmonisation of trial requirements that have delayed patient access to treatment,” former Australian prime minister Kevin Rudd, co-chair of the Bloomberg cancer coalition, said in a statement.

Mary Gospodarowicz, also a member of the coalition, said that it was “challenging” as an oncologist in Canada when a drug was approved in the US but would take years to be able to prescribe it to her patients. 

The study assumed that the rest of the world had the infrastructure to diagnose and treat cancer as well as the US, which is not always the case, Gospodarowicz told AFP via phone from the World Cancer Congress in Geneva on Tuesday.

But it served as an example of how “removing the barriers to drug approval would be beneficial to patients around the world,” said the former president of the Union for International Cancer Control, which is holding the congress. 

The authors of the analysis called on countries to embrace Project Orbis, a US-led framework aiming to get cancer drugs trialled and approved at the same time in multiple countries.

Advertisement
20241211_mh_noexigencia_dui_728x90
20240813_lechematerna_728x91
20240701_vacunacion_728x90
20231124_etesal_728x90_1
domfuturo_netview-728x90
20240604_dom_728x90
20230816_dgs_728x90
20230601_agenda_primera_infancia_728X90
CEL
previous arrow
next arrow

“The US has already made significant progress in setting up the regulatory infrastructure for cancer treatment with the Project Orbis initiative and the task ahead is to take that framework and internationalise it,” former New York mayor Michael Bloomberg said in a statement. 

Continue Reading
Advertisement
20241211_mh_noexigencia_dui_300x250
20240813_lechematerna_300x200_1
20240813_lechematerna_300x200_2
20240701_vacunacion_300x250
20231124_etesal_300x250_1
20230816_dgs_300x250
20230601_agenda_primera_infancia_300X250
MARN1

International

U.S. health authorities report mutation of avian flu virus in Louisiana patient

Chile detects first outbreak of avian flu in poultry; shipments closed: minister

The avian flu virus mutated inside the first seriously ill patient in the United States, according to the country’s health authorities. However, they assured that, so far, no person-to-person transmission of the virus has been identified in this patient, who is hospitalized in Louisiana.

Scientists warned that while it is concerning because mutations could make the virus potentially more transmissible between humans, they would be alarming if found in animal hosts or in the early stages of infection or symptom onset, which would facilitate the spread to close contacts.

The Centers for Disease Control and Prevention (CDC) have identified at least 65 human cases of avian flu in the United States, with more than half (36) reported in California, including the country’s first child infected with this virus.

CDC analysis of the Louisiana patient identified mutations in the hemagglutinin gene, which were not found in the samples from infected poultry at the source of the outbreak. This suggests that the changes emerged as the virus replicated in the seriously ill patient.

Continue Reading

International

José Mujica’s recovery continues with successful stent procedure in esophagus

Former Uruguayan President José Mujica underwent surgery on Friday, during which a stent was successfully placed in his esophagus. In April, a malignant tumor was discovered in the area, which was treated with radiation therapy.

“We did it today because the situation required it at this moment. This will allow him to continue eating orally, continue receiving food as before, and maintain his recovery at home,” explained his personal doctor, Raquel Pannone, in a press conference.

She also took the opportunity to explain how the stent works.

“It is a prosthesis. A device placed inside the esophagus that self-expands. This metal device adheres to the walls of the esophagus and remains there, expanding the esophagus’ opening and allowing the passage of food,” she detailed.

Continue Reading

International

Preliminary Investigation Suggests ‘External Interference’ in Azerbaijan Airlines Plane Crash in Kazakhstan

Azerbaijan Airlines stated on Friday that the plane that crashed in Kazakhstan experienced “external, physical, and technical interference,” based on preliminary investigation results, fueling speculation that the aircraft may have been struck by Russian defense missiles.

The Embraer 190 aircraft, operated by Azerbaijan Airlines and carrying 67 people, was en route from Baku, the capital of Azerbaijan, to Grozny, the capital of the Chechen Republic in Russian territory, when it crashed near Aktau, a port on the Caspian Sea in western Kazakhstan, far from its intended route. The crash resulted in the deaths of 38 people, according to Kazakh authorities.

In response to the incident, Azerbaijan Airlines announced the suspension of its flights to several Russian cities, as the “preliminary results of the investigation into the Embraer 190 crash… point to external, physical, and technical interference.”

Continue Reading

Trending

Central News